Results 11 to 20 of about 7,009,349 (302)

The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing

Mediators of Inflammation, 2023
Background/Aims. The underlying mechanisms of differential responsiveness to IFN remain poorly understood. The elongation factor Tu GTP binding domain-containing protein 2 (EFTUD2), involved in RNA splicing and pre-mRNA processing, was recognized as a ...
Pingping Hu, Yuwen Li, Wen Zhang, Rui Liu, Linya Peng, Ruirui Xu, Jinyuan Cai, Hui Yuan, Tiantong Feng, Anran Tian, Ming Yue, Jun Li, Wenting Li, Chuanlong Zhu   +13 more
doaj   +1 more source

Multinational corporations and infectious disease : embracing human rights management techniques [PDF]

, 2014
Global health institutions have called for governments, international organisations and health practitioners to employ a human rights-based approach to infectious diseases.
Wielga, Mark, Utzinger, Jürg, Salcito, Kendyl, Singer, Burton H., Winkler, Mirko S., Krieger, Gary R., Weiss, Mitchell G., Burton H Singer, Gary R Krieger, Utzinger J, Weiss MG, Winkler MS, Mark Wielga, Krieger GR, Wielga M, Weiss, Mitchell, Mitchell G Weiss, Singer BH, Salcito K, Jürg Utzinger, Kendyl Salcito, Mirko S Winkler   +21 more
core   +1 more source

Unhealthy landscapes: Policy recommendations on land use change and infectious disease emergence. [PDF]

, 2004
Anthropogenic land use changes drive a range of infectious disease outbreaks and emergence events and modify the transmission of endemic infections.
Patz, Jonathan A, Tabor, Gary M, A. Marm Kilpatrick, Daszak, Peter, Molyneux, David, Kilpatrick, A Marm, Jonathan A. Patz, David Molyneux, Peter Daszak, Bradley, David J, Mary Pearl, Johannes Foufopoulos, Nathan D. Wolfe, Working Group on Land Use Change and Disease Emergence, Epstein, Jon, A. Alonso Aguirre, Foufopoulos, Johannes, Aguirre, A Alonso, Pearl, Mary, David J. Bradley, Gary M. Tabor, Wolfe, Nathan D, Jon Epstein, Wolfe, Nathan D., Silbergeld, E., Haines, A., LeBlancq, S., Cunningham, A. A., Ashford, R. W., Rosenthal, J. P., Barthelemy, D., Bos, R., Jamaluddin, A., Lele, S., Randriamanajara, O., Patz, Jonathan A., Furu, P., Corvalan, C., Tabor, Gary M., Riach, J., Koren, H. S., Aguirre, A. Alonso, Graham, D., Thomson, M., Buck, A., Lindsay, S., Pimentel, D., Yameogo, L., Koontz, F., Dobson, A. P., Confalonieri, U. E., Zakarov, V., Butler, C., Epstein, J., Clark, G., McMichael, T., Bradley, D. J., Bradley, David J., Norris, D. E., Colwell, R., Hyatt, A. D., Else, J. G., Kilpatrick, A. Marm, Gascon, C., Rakototiana, L., Chua, K. B., Dein, J., McLean, R. G., Vittor, A. Y., Maynard, N., Chivian, E. S., Salazar-Sanchez, E., Kleinau, E. F., Amerasinghe, F. P., Pearl, M. C., Ostfeld, R. S., Field, H., Morse, S. S.   +77 more
core   +1 more source

A space-time conditional intensity model for infectious disease occurence [PDF]

, 2010
A novel point process model continuous in space-time is proposed for infectious disease data. Modelling is based on the conditional intensity function (CIF) and extends an additive-multiplicative CIF model previously proposed for discrete space epidemic ...
Höhle, Michael, Johannes Elias, Sebastian Meyer, Meyer, Sebastian, Elias, Johannes, Michael Höhle   +5 more
core   +1 more source

Household structure and infectious disease transmission [PDF]

, 2009
One of the central tenets of modern infectious disease epidemiology is that an understanding of heterogeneities, both in host demography and transmission, allows control to be efficiently optimized.
Keeling, M J, House, Thomas A., House, T; id_orcid, Keeling, Matthew James   +3 more
core   +1 more source

A two-component model for counts of infectious diseases [PDF]

, 2005
We propose a stochastic model for the analysis of time series of disease counts as collected in typical surveillance systems on notifiable infectious diseases.
Schmid, V, Held, Leonhard, Höhle, Michael, Held, L, Hofmann, M., Hofmann, Mathias, Höhle, M, Schmid, Volker J., Schmid, Volker, Hofmann, M   +9 more
core   +1 more source

Screening for Latent Tuberculosis Infection using Interferon-Gamma Release Assay Test among Healthcare Workers

Global Medical & Health Communication, 2023
Healthcare workers (HCWs) represent a significant demographic for screening latent tuberculosis infection (LTBI) due to their potential exposure to infectious patients.
Rosamarlina Rosamarlina, Nina Mariana, Titi Sundari, Tri Yuli Setianingsih, Jahiroh Jahiroh, Intan Pertiwi, Aninda Dinar Widiantari, Vivi Setiawaty, Farida Murtiani   +8 more
doaj   +1 more source

A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline

Infectious Diseases and Therapy, 2020
Background Eravacycline is a novel fluorocycline approved for treatment of intraabdominal infections, with a broad spectrum of activity against a range of pathogens including multidrug-resistant species, including ESBL- or KPC-producing isolates.
Nicholas Van Hise, Russell M. Petrak, Nathan C. Skorodin, Robert M. Fliegelman, Michael Anderson, Vishal Didwania, Alice Han, Kairav Shah, Vishnu Chundi, David Hines, Ingrid Roig, Apoorv Kalra   +11 more
doaj   +1 more source

Back Matter

Indonesian Journal of Tropical and Infectious Disease, 2021
Indonesian Journal of Tropical and Infectious Disease
doaj   +5 more sources

Predictive risk score model for severe fever with thrombocytopenia syndrome mortality based on qSOFA and SIRS scoring system

BMC Infectious Diseases, 2020
Background Severe fever with thrombocytopenia syndrome (SFTS) is a severe systemic virus infectious disease usually having multi-organ dysfunction which resembles sepsis.
Li Wang, Zhiqiang Zou, Kun Ding, Chunguo Hou   +3 more
doaj   +1 more source